Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study
Lenalidomide is an immunomodulating derivative of thalidomide, which shows anti-tumor activity against myeloma cells with immunomodulation including augmentation of T-cell and natural killer cell function. Continuous treatment with this agent shows better survival benefit in patients with multiple m...
Main Authors: | Tomoki Ito, Akiko Konishi, Yukie Tsubokura, Yoshiko Azuma, Masaaki Hotta, Hideaki Yoshimura, Takahisa Nakanishi, Shinya Fujita, Aya Nakaya, Atsushi Satake, Kazuyoshi Ishii, Shosaku Nomura |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnut.2018.00072/full |
Similar Items
-
Analysis of the Effects of Ninjin’yoeito on Physical Frailty in Mice
by: Shotaro Otsuka, et al.
Published: (2022-09-01) -
Ninjin’yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice
by: Takeshi Suginohara, et al.
Published: (2022-12-01) -
Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report
by: Hirai Kuniaki, et al.
Published: (2018-09-01) -
Ninjin’yoeito ameliorated PPE-induced pulmonary emphysema and anxiety/depressive-like behavior in aged C57BL/6J mice
by: Taiki Shimoyama, et al.
Published: (2022-10-01) -
Relationship between the severity of pre-frailty and the degree of adaptation of Ninjin’yoeito (NYT) on pre-frailty
by: Haruka Amitani, et al.
Published: (2024-04-01)